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Introduction: The aim of this study was to assess the impact on the surgical unit of the ﬁrst year
(prevalence screening) of non-randomized invitations to 47e49 year old women for breast screening,
from a single breast screening unit.
Methods: All women undergoing surgery in the age group 47e49 years, referred via screening were
identiﬁed and the increased workload analysed.
Results: 4250 (76%) women were screened of the 5624 invited. 396 women were recalled, of whom 88
(22%) underwent a core biopsy. 32 patients required surgical intervention.
20 patients (62.5%) were conﬁrmed to have either DCIS (6 patients) or invasive malignancy (14 patients).
They required 37 theatres attendances requiring 42 operations. 16 wire guided wide local excisions (14
with sentinel node biopsy), 7 mastectomies (2 with sentinel node biopsy; 1 with axillary clearance), 6
margin re-excisions, 1 tissue expander insertion and removal, 3 Latissimus Dorsi with implant and 2 TRAM
reconstructions. Other cases include haematoma drainage, scar revisions and nipple reconstructions. This
group generated 100 NHS surgical outpatient consultations (78 breast and 22 plastic surgery).
12 patients (37.5%) underwent surgery for a B3 vacuum result; 10 underwent wire guided and 1 ultra-
sound guided skin marked excision biopsy. 1 patient was treated privately. This group generated 25 NHS
surgical outpatients consultations.
Conclusions: This study highlights the impact of the 47e49 year age extension within the breast
screening programme on the workload of the surgical department of a UK Breast Cancer Screening Unit
offering non-randomized invitations. The study will inform other surgical units of expected workload
when age extension is fully implemented.
Crown Copyright  2013 Published by Elsevier Ltd on behalf of Surgical Associates Ltd. All rights
reserved.21. Introduction
Breast cancer is the second most common cause of cancer death
inwomen after lung cancer. The publication of The Forrest Report in
19861 led to the implementation of the NHS Breast Screening
Programme (NHSBSP) in 1988. The current programme screens 1.6
million women per year. UK National initiative to extend the age
range of women eligible for breast screening to ages 47e73, from
the current range of 50e70, was proposed in 2007 by The Cancerorate 1, Royal Devon & Exeter
K. Tel.: þ44 (0) 7950771545
. Ariyarathenam).
013 Published by Elsevier Ltd on bReform Strategy. This age extension was started in 2010 and ex-
pected to be nationally implemented by 2016.
Initial pilot studies assessed and conﬁrmed the feasibility and
acceptability of randomizing the phased introduction of this age
extension.3 The North & East Devon Breast Screening Unit (BSU) is
the ﬁrst unit to invite young women in the age group of 47e49,
without randomization. The aim of this study was to assess the
increased impact on the surgical unit due to the prevalence (ﬁrst)
screening round for this lower age extension group.
2. Method
2.1. Screening unit
InHealth Group Ltd operates the stand alone North & East Devon BSU. It operates
both static and mobile digital mammography units with facilities for ultrasound and
stereotactic biopsies. The total screening population served is 80,000.ehalf of Surgical Associates Ltd. All rights reserved.
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The Royal Devon and Exeter NHS Foundation Trust, a medium sized teaching
hospital based in Exeter, Devon, England contains the Surgical Breast Unit and re-
ceives almost all the surgical referrals generated by the North & East Devon Breast
Screening Unit. The Surgical Breast Unit consists of 3 consultant breast surgeons of
whom one is involved in oncoplastic work with the rest of the reconstructions
supported by the plastic surgery department.
2.3. Data
Retrospective data was collected of all women invited to the screening pro-
gramme between the ages 47e49, since the implementation of non-randomized
screening for this group in January 2011. The patients who did not accept the invi-
tation or who were investigated and discharged back to the national screening
programme with no requirement for surgical intervention were then excluded.
The remaining patients’ information was obtained from the electronic record
from the BSU, patients’ notes, histology reports, operation notes and outpatient
clinic letters. The data was analysed on an Excel worksheet.
3. Results
A total of 4250 (76%) women accepted the invitation of the 5624
invited. This lead to initial recall of 396 women of whom 88 (22%)Fig. 1. Flowchart of women in the age group 47e49 who wunderwent an ultrasound or stereotactic core biopsy. 32 patients
subsequently underwent surgical intervention. (Fig. 1).
Group A consists of 20 patients (62.5%) undergoing surgery for
conﬁrmed either DCIS only (6 patients) or invasive malignancy
with or without DCIS (14 patients). These patients required 37
theatres attendances, requiring 42 operations. (Fig. 2) There were
16 wire guided wide local excisions (14 with sentinel node biopsy),
7 mastectomies (2 with sentinel node biopsy; 1 with axillary
clearance) and 6 cavity re-excisions. The remaining operations
were due to immediate reconstruction procedures of 3 Latissimus
Dorsi with implant reconstruction and 2 free TRAM re-
constructions. The rest of the cases were due to insertion and
subsequent removal of a tissue expander insertion, drainage of
haematoma, scar revision and nipple reconstructions. This group
generated a total of 100 surgical outpatient consultations. 78 of
these 100 outpatients were with a breast surgeon (21 pre-operative
and the remaining 57 post-operative/follow up) and the remaining
22 were for consultations with the plastic surgery team.
In the remaining group, Group B, of 12 patients (37.5%) un-
derwent surgery for an indeterminate (B3) result on vacuumere invited, screened, recalled and further investigated.
Fig. 2. Surgical management pathway for Group A patients (Patients with DCIS and/or invasive malignancy).
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the remaining patients, 1 underwent an ultrasound guided skin
marked excision biopsy and the other underwent surgery in
the private sector. This group generated 25 surgical outpatients
consultations.
4. Discussion
This study presents the data from a single UK BSU to invite,
without randomization, all women in the age group of 47e49 for
breast screening. In the UK, the NHS Breast Screening Programme
stipulates a minimum detection rate of invasive tumours of 3.6 per
1000, with an average age at prevalence screen of 51 years.4,5 This is
comparable to the rate of 3.3 per 1000 in our younger population of
women at the prevalence screen.
The impact of this on the surgical department resulted in 125
surgical outpatients consultations and 53 operations.
Majority of the operations are for impalpable lesions detected on
thisprevalence screen, hence themost common typeof surgery in the
Group A was wire guide wide local excision with/without sentinel
node biopsy dependent on the histology of the breast lesion (n¼ 17)
and wire guided excision biopsy for Group B patients (n ¼ 10).
Mastectomy was performed in 35% (n ¼ 7) in Group A patients,
either as primary operation (n ¼ 3) or secondary to a wide local
excision (n ¼ 4). All women undergoing mastectomy (100%) un-
derwent or awaiting a reconstruction (Fig. 2). This is expected as
the younger women are more likely to be medically ﬁt to undergo
reconstruction and more likely to choose this option.
This study examines the increased workload resulting from
extending the prevalence screen to include younger women (aged
47e49) in the NHS Breast Screening Programme, but the existing
resources in the surgical departments absorbed this extra work.
The discussion of the increased ﬁnancial impact for the health
service is more complicated. Even though the increased initialworkload undoubtedly will lead to increase in the cost implication,
the screening of younger womenwill lead to lesions being detected
early and hence more amenable to breast conserving surgery.
Therefore the increased ﬁnancial impact may prove to be beneﬁcial
and more cost effective for the screening programme during the
later incidence screens.
This study is aimed to help other surgical department attached
to BSU in the UK to help prepare in the increased resource demand
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